• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病和新皮质路易体病中 Lemur 酪氨酸激酶 2(LMTK2)的神经病理学特征。

Neuropathological characterization of Lemur tyrosine kinase 2 (LMTK2) in Alzheimer's disease and neocortical Lewy body disease.

机构信息

Department of Pathology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

MTA-DE Cerebrovascular and Neurodegenerative Research Group, Department of Neurology, University of Debrecen, Debrecen, Hungary.

出版信息

Sci Rep. 2019 Nov 20;9(1):17222. doi: 10.1038/s41598-019-53638-9.

DOI:10.1038/s41598-019-53638-9
PMID:31748522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6868282/
Abstract

Alzheimer's disease (AD) and neocortical Lewy body disease (LBD) are the most common neurodegenerative dementias, with no available curative treatment. Elucidating pathomechanism and identifying novel therapeutic targets are of paramount importance. Lemur tyrosine kinase 2 (LMTK2) is involved in several physiological and pathological cellular processes. Herewith a neuropathological characterization is presented in AD and neocortical LBD samples using chromogenic and fluorescent LMTK2 immunohistochemistry on post-mortem brain tissues and compared them to age-matched controls (CNTs). LMTK2 immunopositivity was limited to the neuronal cytoplasm. Neurons, including tau-positive tangle-bearing ones, showed decreased chromogenic and immunofluorescent labelling in AD in every cortical layer compared to CNT and neocortical LBD. Digital image analysis was performed to measure the average immunopositivity of groups. Mean grey values were calculated for each group after measuring the grey scale LMTK2 signal intensity of each individual neuron. There was significant difference between the mean grey values of CNT vs. AD and neocortical LBD vs. AD. The moderate decrease in neocortical LBD suggests the effect of coexisting AD pathology. We provide neuropathological evidence on decreased neuronal LMTK2 immunolabelling in AD, with implications for pathogenesis.

摘要

阿尔茨海默病(AD)和新皮质路易体病(LBD)是最常见的神经退行性痴呆症,目前尚无有效的治疗方法。阐明发病机制和寻找新的治疗靶点至关重要。狐猴酪氨酸激酶 2(LMTK2)参与了多种生理和病理细胞过程。本研究通过对死后脑组织进行显色和荧光 LMTK2 免疫组织化学染色,对 AD 和新皮质 LBD 样本进行了神经病理学特征描述,并将其与年龄匹配的对照组(CNT)进行了比较。LMTK2 免疫阳性仅限于神经元细胞质。与 CNT 和新皮质 LBD 相比,AD 患者的每个皮质层中,包括 tau 阳性缠结的神经元在内,其显色和免疫荧光标记均减少。进行了数字图像分析,以测量各组的平均免疫阳性率。在测量每个神经元的 LMTK2 信号强度的灰度值后,计算每组的平均灰度值。CNT 与 AD 以及新皮质 LBD 与 AD 之间的平均灰度值存在显著差异。新皮质 LBD 的中度减少表明存在共存的 AD 病理学的影响。我们提供了 AD 中神经元 LMTK2 免疫标记减少的神经病理学证据,这对发病机制具有重要意义。

相似文献

1
Neuropathological characterization of Lemur tyrosine kinase 2 (LMTK2) in Alzheimer's disease and neocortical Lewy body disease.阿尔茨海默病和新皮质路易体病中 Lemur 酪氨酸激酶 2(LMTK2)的神经病理学特征。
Sci Rep. 2019 Nov 20;9(1):17222. doi: 10.1038/s41598-019-53638-9.
2
Tau pathology associates with in vivo cortical thinning in Lewy body disorders.在路易体疾病中,tau病理改变与体内皮质变薄相关。
Ann Clin Transl Neurol. 2020 Dec;7(12):2342-2355. doi: 10.1002/acn3.51183. Epub 2020 Oct 27.
3
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.路易体病中 tau 病理学的认知和病理影响。
Ann Neurol. 2019 Feb;85(2):259-271. doi: 10.1002/ana.25392. Epub 2019 Jan 7.
4
Lemur Tyrosine Kinase 2 (LMTK2) Level Inversely Correlates with Phospho-Tau in Neuropathological Stages of Alzheimer's Disease.狐猴酪氨酸激酶2(LMTK2)水平与阿尔茨海默病神经病理阶段的磷酸化tau呈负相关。
Brain Sci. 2020 Jan 27;10(2):68. doi: 10.3390/brainsci10020068.
5
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.神经病理学混合性阿尔茨海默病和路易体病:临床表型之间病理蛋白聚集物的负担不同。
Acta Neuropathol. 2015 May;129(5):729-48. doi: 10.1007/s00401-015-1406-3. Epub 2015 Mar 11.
6
Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.阿尔茨海默病和路易体痴呆患者新皮质中转化生长因子β2升高与疾病严重程度及可溶性Aβ42负荷相关。
J Alzheimers Dis. 2017;56(1):157-166. doi: 10.3233/JAD-160781.
7
Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease.帕金森病和路易体病患者额前皮质二酰基甘油水平升高。
PLoS One. 2018 Mar 7;13(3):e0191815. doi: 10.1371/journal.pone.0191815. eCollection 2018.
8
Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.Lewy 相关病理学神经病理学诊断中α-突触核蛋白、淀粉样β 和磷酸化 tau 病理学的显著重叠:来自中国人类脑库的证据。
J Alzheimers Dis. 2021;80(1):447-458. doi: 10.3233/JAD-201548.
9
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.溶酶体组织蛋白酶 D 在阿尔茨海默病患者新皮质中上调,可能是神经纤维缠结变性的标志物。
Brain Pathol. 2019 Jan;29(1):63-74. doi: 10.1111/bpa.12631. Epub 2018 Oct 17.
10
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias.在晚期阿尔茨海默病的新皮层中,炎症因子谱细胞因子升高,但在路易体痴呆症中则没有。
J Neuroinflammation. 2023 May 8;20(1):111. doi: 10.1186/s12974-023-02789-8.

引用本文的文献

1
LMTK2 and CRB1 are two novel risk genes for Alzheimer's disease in Han Chinese.LMTK2和CRB1是汉族人群中阿尔茨海默病的两个新的风险基因。
J Prev Alzheimers Dis. 2025 May;12(5):100087. doi: 10.1016/j.tjpad.2025.100087. Epub 2025 Feb 7.
2
The lemur tail kinase family in neuronal function and disfunction in neurodegenerative diseases.神经退行性疾病中神经元功能和紊乱的狐猴尾巴激酶家族。
Cell Mol Life Sci. 2024 Nov 9;81(1):447. doi: 10.1007/s00018-024-05480-0.
3
Therapeutic advances of targeting receptor tyrosine kinases in cancer.

本文引用的文献

1
LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer's disease brains.LMTK2 与驱动蛋白轻链结合,介导 CDK5/p35 的顺行轴突运输,并且 LMTK2 水平在阿尔茨海默病大脑中降低。
Acta Neuropathol Commun. 2019 May 8;7(1):73. doi: 10.1186/s40478-019-0715-5.
2
Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration.Lemur 酪氨酸激酶 2(LMTK2)的生物学功能:在神经退行性变中的意义。
Mol Brain. 2018 Apr 10;11(1):20. doi: 10.1186/s13041-018-0363-x.
3
Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.
靶向治疗癌症受体酪氨酸激酶的治疗进展。
Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w.
4
A revised nomenclature for the lemur family of protein kinases.更新的灵长目蛋白激酶家族命名法。
Commun Biol. 2024 Jan 8;7(1):57. doi: 10.1038/s42003-023-05671-8.
5
Dementia with Lewy bodies - a clinicopathological update.路易体痴呆——临床病理新进展
Free Neuropathol. 2020 Feb 18;1:7. doi: 10.17879/freeneuropathology-2020-2613. eCollection 2020 Jan.
6
Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation.载脂蛋白 E4 与补体因子 H 结合减少可促进淀粉样β 寡聚化和神经炎症。
EMBO Rep. 2023 Jul 5;24(7):e56467. doi: 10.15252/embr.202256467. Epub 2023 May 8.
7
Convergent coexpression of autism-associated genes suggests some novel risk genes may not be detectable in large-scale genetic studies.自闭症相关基因的趋同共表达表明,一些新的风险基因可能在大规模基因研究中无法被检测到。
Cell Genom. 2023 Mar 9;3(4):100277. doi: 10.1016/j.xgen.2023.100277. eCollection 2023 Apr 12.
8
Comparison of Semi-Quantitative Scoring and Artificial Intelligence Aided Digital Image Analysis of Chromogenic Immunohistochemistry.半定量评分与人工智能辅助显色免疫组化数字图像分析的比较。
Biomolecules. 2021 Dec 23;12(1):19. doi: 10.3390/biom12010019.
9
Differential Gene Expression Analysis Reveals Global LMTK2 Regulatory Network and Its Role in TGF-β1 Signaling.差异基因表达分析揭示了全局LMTK2调控网络及其在TGF-β1信号传导中的作用。
Front Oncol. 2021 Mar 18;11:596861. doi: 10.3389/fonc.2021.596861. eCollection 2021.
10
Extracellular matrix changes in corneal opacification vary depending on etiology.角膜混浊的细胞外基质变化因病因而异。
Mol Vis. 2021 Jan 15;27:26-36. eCollection 2021.
神经退行性疾病认知衰退的突触标志物:一种蛋白质组学方法。
Brain. 2018 Feb 1;141(2):582-595. doi: 10.1093/brain/awx352.
4
Activation of TPA-response element present in human Lemur Tyrosine Kinase 2 () gene increases its expression.人狐猴酪氨酸激酶2()基因中存在的TPA反应元件的激活会增加其表达。
Biochem Biophys Rep. 2017 Sep 21;12:140-150. doi: 10.1016/j.bbrep.2017.09.006. eCollection 2017 Dec.
5
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.路易体痴呆的诊断与管理:DLB联盟第四次共识报告
Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7.
6
Kinase modulation of androgen receptor signaling: implications for prostate cancer.激酶对雄激素受体信号传导的调节:对前列腺癌的影响
Cancer Cell Microenviron. 2015;2(4). doi: 10.14800/ccm.1023. Epub 2015 Nov 19.
7
Cancer and neurodegeneration: two sides, same coin?癌症与神经退行性疾病:一体两面?
Oncotarget. 2017 Apr 4;8(14):22307-22308. doi: 10.18632/oncotarget.16190.
8
Roles of tau protein in health and disease.tau蛋白在健康与疾病中的作用。
Acta Neuropathol. 2017 May;133(5):665-704. doi: 10.1007/s00401-017-1707-9. Epub 2017 Apr 6.
9
Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members.狐猴酪氨酸激酶2(LMTK2)通过调节BCL2家族成员的水平来决定细胞对凋亡的敏感性。
Cancer Lett. 2017 Mar 28;389:59-69. doi: 10.1016/j.canlet.2016.12.025. Epub 2016 Dec 29.
10
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.突触蛋白可预测阿尔茨海默病和路易体痴呆的认知能力下降。
Alzheimers Dement. 2016 Nov;12(11):1149-1158. doi: 10.1016/j.jalz.2016.04.005. Epub 2016 May 22.